Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.

Yardley DA; Noguchi S; Pritchard KI; Burris HA 3rd; Baselga J; Gnant M; Hortobagyi GN; Campone M; Pistilli B; Piccart M

doi:10.1007/s12325-013-0060-1

Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.

Identifier:nobleid.org/w1/20260526/449EB10D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/449EB10D.svg?ark=w1%2F20260526%2F449EB10D)](https://nobleid.org/work/w1/20260526/449EB10D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.

Identifier:nobleid.org/w1/20260526/449EB10D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/449EB10D.svg?ark=w1%2F20260526%2F449EB10D)](https://nobleid.org/work/w1/20260526/449EB10D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work